1. Home
  2. CCLD vs COYA Comparison

CCLD vs COYA Comparison

Compare CCLD & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareCloud Inc.

CCLD

CareCloud Inc.

N/A

Current Price

$1.73

Market Cap

98.6M

Sector

Technology

ML Signal

N/A

Logo Coya Therapeutics Inc.

COYA

Coya Therapeutics Inc.

N/A

Current Price

$3.18

Market Cap

102.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CCLD
COYA
Founded
1999
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
98.6M
102.7M
IPO Year
2013
2022

Fundamental Metrics

Financial Performance
Metric
CCLD
COYA
Price
$1.73
$3.18
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
$7.33
★ $15.21
AVG Volume (30 Days)
★ 218.7K
127.0K
Earning Date
11-05-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 135.71
N/A
EPS
★ N/A
N/A
Revenue
★ $120,499,000.00
$7,945,753.00
Revenue This Year
$8.14
N/A
Revenue Next Year
$9.63
$387.14
P/E Ratio
★ N/A
N/A
Revenue Growth
8.72
★ 123.57
52 Week Low
$1.69
$3.60
52 Week High
$3.81
$6.62

Technical Indicators

Market Signals
Indicator
CCLD
COYA
Relative Strength Index (RSI) 38.76 22.34
Support Level N/A N/A
Resistance Level $2.42 $5.17
Average True Range (ATR) 0.09 0.32
MACD 0.01 -0.08
Stochastic Oscillator 28.57 1.79

Price Performance

Historical Comparison
CCLD
COYA

About CCLD CareCloud Inc.

CareCloud Inc delivers flexible, tech-enabled solutions for healthcare providers of all sizes and multi-specialties across the U.S. It is a healthcare technology company offering cloud-based solutions that simplify clinical, administrative, and financial workflows for medical practices of all sizes. Its comprehensive suite includes Electronic Health Records (EHRs), Practice Management, Revenue Cycle Management (RCM), Medical Billing, Telehealth, and Patient Experience solutions. The group helps practices increase efficiency, improve patient care, and drive sustainable growth-all while ensuring HIPAA compliance and seamless integration. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.

About COYA Coya Therapeutics Inc.

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.

Share on Social Networks: